Dr. Anh Hoang-Lindsay is the CEO of Jana Care Inc, a pioneering developer of at-home, self-administered blood testing technologies for heart disease and chronic kidney disease management. The platform enables patients to self-administer blood tests at-home and allows clinicians to review the test results remotely as needed. Prior to Jana Care, she was the founder of Sofregen Medical, a company that is re-inventing ancient silk technologies to restore tissue volume. At Sofregen, Anh operates as the chief science officer and serves on the board of directors. Under her leadership, Sofregen received the first FDA cleared product made from reconstituted silk protein for the treatment of vocal fold insufficiency. Outside of Jana Care, Anh is a part time faculty at MIT’s Catalyst Program, a member of the board of directors of MassMedic, and serves as an advisor to several early stage companies and venture funds. She was a recipient of the 2018 Medtech Boston 40 under 40 Healthcare Innovators. Anh completed her doctorate degree (Ph.D) in material science engineering from Vanderbilt University and her postdoctoral fellowship at Harvard Medical School and Mass General Hospital as an Executive Committee on Research fellow.